Kevin Outterson
Kevin Outterson is a lawyer, and the N. Neal Pike Scholar in Health and Disability Law at Boston University (2014–present). He is the Executive Director of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X),[1] a global non-profit partnership focused on accelerating the early development of innovative antibiotics, diagnostics, vaccines and other products to tackle drug-resistant bacterial infections.
He is Co-director of the health law program at Boston University School of Law (2007–present) and associate fellow at the Royal Institute of International Affairs at Chatham House, London (2014–present). He serves on the Board of the American Society of Law, Medicine & Ethics (2010–present), and as faculty editor to the American Journal of Law & Medicine (2007–present). He is past editor-in-chief of the Journal of Law, Medicine & Ethics (2010–2016).[1]
References
- ^ a b "Kevin Outterson | School of Law". www.bu.edu. Retrieved 12 May 2020.
External links
- Kevin Outterson publications indexed by Google Scholar
| International | |
|---|---|
| National | |
| Academics | |
  | This American law–related biographical article is a stub. You can help Wikipedia by expanding it. |